EPISODE · May 14, 2021 · 1H 2M
COVID Vaccine Update #7:Expanded EUA for Use of Pfizer mRNA Vaccine in Adolescents 12-15Years of Age
from The Health In Harlem Podcast · host healthinharlem
The fight against SARS-CoV-2 continues and fortunately, here in the United States it's like we have a wave of reinforcements that can potentially join the fray as the Food and Drug Administration revised the Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents ages 12-15 as eligible to receive the jab. The race continues to vaccinate as many people as possible in order to get better control of this outbreak and thus get to some sense of normalcy in our lives. In this latest episode of Health In Harlem we discuss the effectiveness of the COVID-19 vaccines, their safety, the rise of variants, and our charge to herd immunity (yes, there is still some hope; especially if more folks roll up their sleeves!). Enjoy, and be sure to check out the resources below for more information: Food and Drug Administration: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use The New York Times: FDA Authorizes Pfizer-BioNTech Vaccine for Children 12-15 https://www.nytimes.com/2021/05/10/health/pfizer-vaccine-children-kids.html The New York Times: Reaching 'Herd Immunity' is Unlikely in the U.S., Experts Now Believe https://www.nytimes.com/2021/05/03/health/covid-herd-immunity-vaccine.html Centers for Disease Control and Prevention: Key Things to Know About COVID-19 Vaccines https://www.cdc.gov/coronavirus/2019-ncov/vaccines/keythingstoknow.html
Embed this episode
NOW PLAYING
COVID Vaccine Update #7:Expanded EUA for Use of Pfizer mRNA Vaccine in Adolescents 12-15Years of Age
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.